Defective mitochondrial adenosine triphosphate production in skeletal muscle from patients with dominant optic atrophy due to OPA1 mutations

Archives of Neurology

Volumn 68, Issue 1, 2011, Pages 67-73

  Lodi, Raffaele ^a   Tonon, Caterina ^a   Valentino, Maria Lucia ^a   Manners, David ^a   Testa, Claudia ^a   Malucelli, Emil ^a   La Morgia, Chiara ^a   Barboni, Piero ^a   Carbonelli, Michele ^a   Schimpf, Simone ^c   Wissinger, Bernd ^c   Zeviani, Massimo ^b   Baruzzi, Agostino ^a   Liguori, Rocco ^a   Barbiroli, Bruno ^a   Carelli, Valerio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b National Neurological Institute   (Italy)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; DYNAMIN; LACTIC ACID; MITOCHONDRIAL DNA; PROTEIN OPA1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT OPTIC ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; ENERGY METABOLISM; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN TISSUE; LACTATE BLOOD LEVEL; MALE; MISSENSE MUTATION; MUSCLE BIOPSY; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 78651304811     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2010.228     Document Type: Article

References (35)

1. Kjer P. Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families. Acta Ophthalmol Suppl. 1959;164(suppl 54):1-147.
2. Delettre C, Lenaers G, Pelloquin L, Belenguer P, Hamel CP. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease. Mol Genet Metab. 2002;75(2):97-107.
3. Olichon A, Guillou E, Delettre C, et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta. 2006;1763(5-6):500-509.
4. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53-89.
5. Delettre C, Lenaers G, Griffoin JM, et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet. 2000;26(2):207-210.
6. Alexander C, Votruba M, Pesch UE, et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet. 2000;26(2):211-215.
7. Ferré M, Amati-Bonneau P, Tourmen Y, Malthièry Y, Reynier P. eOPA1: an online database for OPA1 mutations. Hum Mutat. 2005;25(5):423-428.
8. Amati-Bonneau P, Valentino ML, Reynier P, et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy "plus" phenotypes. Brain. 2008;131(pt 2):338-351.
9. Hudson G, Amati-Bonneau P, Blakely EL, et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 2008;131(pt 2):329-337.
10. Ferraris S, Clark S, Garelli E, et al. Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1. Arch Neurol. 2008;65(1):125-131.
11. Stewart JD, Hudson G, Yu-Wai-Man P, et al. OPA1 in multiple mitochondrial DNA deletion disorders. Neurology. 2008;71(22):1829-1831.
12. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010;133(pt 3):771-786.
13. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci. 2008;9(7):505-518.
14. Zanna C, Ghelli A, Porcelli AM, et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain. 2008;131(pt 2):352-367.
15. Olichon A, Baricault L, Gas N, et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem. 2003;278(10):7743-7746.
16. Frezza C, Cipolat S, Martins de Brito O, et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126(1):177-189.
17. Lodi R, Tonon C, Valentino ML, et al. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy. Ann Neurol. 2004;56(5):719-723.
18. Amati-Bonneau P, Guichet A, Olichon A, et al. OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol. 2005;58(6):958-963.
19. Chevrollier A, Guillet V, Loiseau D, et al. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol. 2008;63(6):794-798.
20. Spinazzi M, Cazzola S, Bortolozzi M, et al. A novel deletion in the GTPase domain of OPA1 causes defects in mitochondrial morphology and distribution, but not in function. Hum Mol Genet. 2008;17(21):3291-3302.
21. Mayorov VI, Lowrey AJ, Biousse V, Newman NJ, Cline SD, Brown MD. Mitochondrial oxidative phosphorylation in autosomal dominant optic atrophy. BMC Biochem. 2008;9:22.
22. Montagna P, Plazzi G, Cortelli P, et al. Abnormal lactate after effort in healthy carriers of Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry. 1995;58(5):640-641.
23. Pesch UEA, Leo-Kottler B, Mayer S, et al. OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance. Hum Mol Genet. 2001;10(13):1359-1368.
24. Schimpf S, Schaich S, Wissinger B. Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene. Hum Genet. 2006;118(6):767-771.
25. Martinuzzi A, Liava A, Trevisi E, et al. Randomized, placebo-controlled, doubleblind pilot trial of ramipril in McArdle's disease. Muscle Nerve. 2008;37(3):350-357.
26. Arnold DL, Taylor DJ, Radda GK. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy. Ann Neurol. 1985;18(2):189-196.
27. Barbiroli B, Montagna P, Cortelli P, et al. Defective brain and muscle energy metabolism shown by in vivo 31P magnetic resonance spectroscopy in nonaffected carriers of 11778 mtDNA mutation. Neurology. 1995;45(7):1364-1369.
28. Lodi R, Taylor DJ, Tabrizi SJ, et al. In vivo skeletal muscle mitochondrial function in Leber's hereditary optic neuropathy assessed by 31P magnetic resonance spectroscopy. Ann Neurol. 1997;42(4):573-579.
29. Larsson NG, Andersen O, Holme E, Oldfors A, Wahlström J. Leber's hereditary optic neuropathy and complex I deficiency in muscle. Ann Neurol. 1991;30(5):701-708.
30. Carelli V, Barboni P, Zacchini A, et al. Leber's hereditary optic neuropathy (LHON) with 14484/ND6 mutation in a North African patient. J Neurol Sci. 1998;160 (2):183-188.
31. Valentino ML, Barboni P, Ghelli A, et al. The ND1 gene of complex I is a mutational hot spot for Leber's hereditary optic neuropathy. Ann Neurol. 2004;56(5):631-641.
32. Yu-Wai-Man P, Davies VJ, Piechota MJ, Cree LM, Votruba M, Chinnery PF. Secondary mtDNA defects do not cause optic nerve dysfunction in amouse model of dominant optic atrophy. Invest Ophthalmol Vis Sci. 2009;50(10):4561-4566.
33. Carelli V, La Morgia C, Iommarini L, et al. Mitochondrial optic neuropathies: how two genomes may kill the same cell type? Biosci Rep. 2007;27(1-3):173-184.
34. Yu-Wai-Man P, Griffiths PG, Hudson G, Chinnery PF. Inherited mitochondrial optic neuropathies. J Med Genet. 2009;46(3):145-158.
35. Lodi R, Montagna P, Cortelli P, et al. "Secondary" 4216/ND1 and 13708/ND5 Leber's hereditary optic neuropathy mitochondrial DNA mutations do not further impair in vivo mitochondrial oxidative metabolism when associated with the 11778/ND4 mitochondrial DNA mutation. Brain. 2000;123(pt 9):1896-1902.